LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 107 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,408 | -16.3% | 7,125 | 0.0% | 0.00% | – |
| Q2 2023 | $10,046 | -76.7% | 7,125 | -59.5% | 0.00% | -100.0% |
| Q4 2021 | $43,051 | -10.5% | 17,572 | -7.9% | 0.00% | 0.0% |
| Q3 2021 | $48,077 | -56.4% | 19,078 | -50.7% | 0.00% | -50.0% |
| Q2 2021 | $110,321 | – | 38,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 5,036,720 | $14,354,000 | 4.77% |
| BROADWOOD CAPITAL INC | 34,005,379 | $96,915,000 | 4.33% |
| Prescott General Partners LLC | 1,851,851 | $5,278,000 | 0.17% |
| Raffles Associates | 43,590 | $124,000 | 0.10% |
| Laidlaw Wealth Management LLC | 123,730 | $353,000 | 0.09% |
| DCF Advisers, LLC | 74,500 | $212,000 | 0.08% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $128,000 | 0.07% |
| Strategic Wealth Investment Group, LLC | 64,232 | $183,000 | 0.06% |
| Paradigm, Strategies in Wealth Management, LLC | 19,775 | $56,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $137,000 | 0.05% |